Benlysta (belimumab)

What it is

Benlysta (belimumab) was the first medicine developed specifically for lupus. It blocks a protein called BLyS (B-lymphocyte stimulator) that helps harmful B cells — white blood cells that make the antibodies involved in lupus — survive. With fewer of these cells surviving, lupus activity settles down. It is used together with standard lupus medicines for systemic lupus erythematosus (SLE) and for lupus nephritis, lupus that affects the kidneys. It comes in two forms — a clinic infusion and a home injection — with the same active medicine.

Before starting

Before starting, we review your infection history, your current lupus medicines, and your vaccination status. Live vaccines should not be given during treatment with Benlysta, and vaccines in general work better before immune-calming treatment begins, so bringing vaccinations up to date first is worthwhile. Treatment is not started during an active infection. Benlysta has not been studied for severe, active lupus affecting the brain or spinal cord, which is treated differently. Tell us if you have a history of depression or mood problems, so we can include mood in what we watch together — a small number of patients in studies reported mood changes, and knowing your baseline helps us spot any change early.

How it’s given

It can be given in two ways: as an IV infusion in our infusion suite once a month (after three starter infusions two weeks apart), or as an injection under the skin once a week at home with an autoinjector pen. Your provider will help you choose the option that fits you best — some patients prefer one monthly visit with nothing to manage at home; others prefer the weekly home injection. If you inject at home, store pens in the refrigerator and rotate sites between the thigh and belly.

What to expect

Benlysta works gradually. Lupus improvement — less fatigue, fewer rashes and joint flares, falling urine protein in kidney lupus — usually builds over 3–6 months, so it is important not to judge it in the first few weeks. The most common side effects are nausea, diarrhoea, fever, headache, trouble sleeping, and cold or bronchitis-like infections; infusion or injection reactions can occur, which is why the team observes you after clinic doses. Because Benlysta calms part of the immune system, infections may be more likely — call us promptly for fever or an infection that is not improving. Report new or worsening low mood as well, so we can help promptly.

Everyday guidance

Keep doses on schedule — monthly infusions or weekly injections — because the benefit depends on steady treatment, and lupus tends to flare when treatment lapses. Continue your other lupus medicines unless your provider changes them. If you are ill with an infection near a dose date, call us first; we may delay the dose until you recover. Tell other clinicians you take an immune-calming medicine, and check with us before vaccines or surgery. If you are planning a pregnancy, discuss it with your provider ahead of time. Our number is (361) 400-7700.